Tag: surgicalMargins

Surgical margins: A disease-free border around a tumor that has been surgically removed. Surgical margins are considered to be positive if the pathologist finds cancer cells right up to the edge of the excised tissue.

News

10/18/15
05/24/12
05/06/12
03/04/12
12/04/11
11/04/10
10/19/10
03/22/10

Studies

  • Phyllodes tumors of the breast: a retrospective analysis of 57 cases Cite
    Noordman PCW, Klioueva NM, Weimann MN, Borgstein PJ, Vrouenraets BC. Phyllodes tumors of the breast: a retrospective analysis of 57 cases. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 181:361-367 10.1007/s10549-020-05620-7
  • The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis Cite
    Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V, et al. The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:4628-4636 10.1245/s10434-020-08878-9
  • Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience Cite
    Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, et al. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09042-z
  • Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact Cite
    Schnitt SJ, Moran MS, Giuliano AE. Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:2240-2245 10.1200/jco.19.03213
  • Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast Cite
    Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, et al. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. npj Breast Cancer. Springer Science and Business Media LLC; 2019; 5 10.1038/s41523-019-0125-7
  • Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses Cite
    Visser LL, Groen EJ, van Leeuwen FE, Lips EH, Schmidt MK, Wesseling J. Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2019; 28:835-845 10.1158/1055-9965.epi-18-0976
  • Impact of SSO-ASTRO margin guidelines on reoperation rates following breast-conserving surgery Cite
    Monaghan A, Chapinal N, Hughes L, Baliski C. Impact of SSO-ASTRO margin guidelines on reoperation rates following breast-conserving surgery. The American Journal of Surgery. Elsevier BV; 2019; 217:862-867 10.1016/j.amjsurg.2019.01.007
  • Impact of obesity on breast cancer recurrence and minimal residual disease Cite
    Ecker BL, Lee JY, Sterner CJ, Solomon AC, Pant DK, Shen F, et al. Impact of obesity on breast cancer recurrence and minimal residual disease. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-018-1087-7
  • Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience Cite
    Hoffman DI, Zhang PJ, Tchou J. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience. Surgical Oncology. Elsevier BV; 2019; 28:190-194 10.1016/j.suronc.2019.01.009
  • No Ink on Ductal Carcinoma In Situ: A Single Centre Experience Cite
    FREGATTI P, GIPPONI M, DEPAOLI F, MURELLI F, GUENZI M, BONZANO E, et al. No Ink on Ductal Carcinoma In Situ: A Single Centre Experience. Anticancer Research. Anticancer Research USA Inc.; 2018; 39:459-466 10.21873/anticanres.13134
  • Radiation Therapy for Positive Surgical Margins in Women ≥70 Years with Stage I, Estrogen Receptor-positive Breast Cancer Cite
    ZHOU M, PEDDI P, CHU QD. Radiation Therapy for Positive Surgical Margins in Women ≥70 Years with Stage I, Estrogen Receptor-positive Breast Cancer. Anticancer Research. Anticancer Research USA Inc.; 2018; 38:5253-5260 10.21873/anticanres.12850
  • Risk factors for loco-regional recurrence after breast conserving surgery: impact of young age and surgical margin status in breast cancer patients Cite
    Vasigh M, Rahmani S, Omranipour R, Haghighat S, Olfatbakhsh E, Kenari AY. Risk factors for loco-regional recurrence after breast conserving surgery: impact of young age and surgical margin status in breast cancer patients. International Surgery Journal. Medip Academy; 2018; 5:2952 10.18203/2349-2902.isj20183713
  • Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected? Cite
    Chagpar AB, Tsangaris TN, Lannin DR. Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?. Journal of the American College of Surgeons. Elsevier BV; 2018; 227:13-21 10.1016/j.jamcollsurg.2018.03.003
  • Management of positive margins after initial lumpectomy in elderly women with breast cancer Cite
    Angarita FA, Acuna SA, McCready DR, Escallon J. Management of positive margins after initial lumpectomy in elderly women with breast cancer. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:1048-1053 10.1016/j.ejso.2018.02.011
  • Risk of death from breast cancer after treatment for ductal carcinoma in situ Cite
    Wadsten C, Garmo H, Fredriksson I, Sund M, Wärnberg F. Risk of death from breast cancer after treatment for ductal carcinoma in situ. British Journal of Surgery. Oxford University Press (OUP); 2017; 104:1506-1513 10.1002/bjs.10589
  • Breast-Conserving Surgery Alone for Ductal Carcinoma In Situ: Factors Associated with Increased Risk of Local Recurrence Cite
    Mele A, Mehta P, Slanetz PJ, Brook A, Recht A, Sharma R. Breast-Conserving Surgery Alone for Ductal Carcinoma In Situ: Factors Associated with Increased Risk of Local Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 24:1221-1226 10.1245/s10434-016-5711-4
  • Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situ Cite
    Mathew J, Karia R, Morgan D, Lee A, Ellis I, Robertson J, et al. Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situ. The Breast. Elsevier BV; 2017; 31:181-185 10.1016/j.breast.2016.11.002
  • Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database Cite
    Landercasper J, Bennie B, Parsons BM, Dietrich LL, Greenberg CC, Wilke LG, et al. Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:1507-1515 10.1245/s10434-016-5760-8
  • Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery? Cite
    Hennigs A, Fuchs V, Sinn H, Riedel F, Rauch G, Smetanay K, et al. Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 23:1831-1837 10.1245/s10434-015-5067-1
  • Neoadjuvant chemotherapy in breast-conserving surgery – Consequences on margin status and excision volumes Cite
    Volders J, Haloua M, Krekel N, Negenborn V, Barbé E, Sietses C, et al. Neoadjuvant chemotherapy in breast-conserving surgery – Consequences on margin status and excision volumes. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:986-993 10.1016/j.ejso.2016.02.252
  • Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period Cite
    Bosma SCJ, van der Leij F, van Werkhoven E, Bartelink H, Wesseling J, Linn S, et al. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:391-400 10.1007/s10549-016-3732-0
  • Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ Cite
    Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2015; 262:623-631 10.1097/sla.0000000000001454
  • Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome Cite
    Karanlik H, Ozgur I, Cabioglu N, Sen F, Erturk K, Kilic B, et al. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2015; 41:1226-1233 10.1016/j.ejso.2015.06.003
  • Rates of residual disease with close but negative margins in breast cancer surgery Cite
    Garvey EM, Senior DA, Pockaj BA, Wasif N, Dueck AC, McCullough AE, et al. Rates of residual disease with close but negative margins in breast cancer surgery. The Breast. Elsevier BV; 2015; 24:413-417 10.1016/j.breast.2015.03.005
  • Risk of Local Failure in Breast Cancer Patients With Lobular Carcinoma In Situ at the Final Surgical Margins: Is Re-excision Necessary? Cite
    Sadek BT, Shenouda MN, Abi Raad RF, Niemierko A, Keruakous AR, Goldberg SI, et al. Risk of Local Failure in Breast Cancer Patients With Lobular Carcinoma In Situ at the Final Surgical Margins: Is Re-excision Necessary?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 87:726-730 10.1016/j.ijrobp.2013.08.012
  • Therapeutic Mammaplasty for Breast Cancer: Oncological and Aesthetic Outcomes Cite
    Grubnik A, Benn C, Edwards G. Therapeutic Mammaplasty for Breast Cancer: Oncological and Aesthetic Outcomes. World Journal of Surgery. Springer Science and Business Media LLC; 2012; 37:72-83 10.1007/s00268-012-1786-7
  • Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy Cite
    Sioshansi S, Ehdaivand S, Cramer C, Lomme MM, Price LL, Wazer DE. Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy. Cancer. Wiley; 2012; 118:3893-3898 10.1002/cncr.27376
  • Accuracy and Completeness of Pathology Reporting — Impact on Partial Breast Irradiation Eligibility Cite
    Pignol J, Rakovitch E, Zeppieri J, Hanna W. Accuracy and Completeness of Pathology Reporting — Impact on Partial Breast Irradiation Eligibility. Clinical Oncology. Elsevier BV; 2012; 24:177-182 10.1016/j.clon.2011.09.004
  • Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Cite
    Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 18:3164-3173 10.1245/s10434-011-1920-z
  • Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period Cite
    Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, et al. Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 19:1107-1114 10.1245/s10434-011-1907-9
  • Clear margins for invasive lobular carcinoma: A surgical challenge Cite
    Sakr R, Poulet B, Kaufman G, Nos C, Clough K. Clear margins for invasive lobular carcinoma: A surgical challenge. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:350-356 10.1016/j.ejso.2011.01.010
  • Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeons Cite
    Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, et al. Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeons. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:92-104 10.1093/jnci/djq499
  • Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit Cite
    Cain H, Sinclair J, Martin A, Fasih T, Browell D, Clark K, et al. Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2680
  • A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery Cite
    Ward ST, Jones BG, Jewkes AJ. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery. International Journal of Clinical Practice. Wiley; 2010; 64:1675-1680 10.1111/j.1742-1241.2010.02508.x
  • Determination of clear margin in breast-conserving surgery: Is 1 mm needed? Cite
    Geffrelot J, Toudic Emily F, Levy C, Blanc Fournier C, Segura C, Switsers O, et al. Determination of clear margin in breast-conserving surgery: Is 1 mm needed?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:515-515 10.1200/jco.2010.28.15_suppl.515
  • Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts). Cite
    De Mattos-Arruda L, Rubio I, Garcia-Aceituno L, Cortes J, Sanchez-Olle G, Peg V, et al. Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11065-e11065 10.1200/jco.2010.28.15_suppl.e11065
  • The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy Cite
    Rudloff U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, et al. The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2010; 251:583-591 10.1097/sla.0b013e3181b5931e
  • The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ Cite
    Song HM, Styblo TM, Carlson GW, Losken A. The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ. The Breast Journal. Wiley; 2010; 16:141-146 10.1111/j.1524-4741.2009.00891.x
  • Subsets of Women with Close or Positive Margins after Breast Conserving Surgery with High Local Recurrence Risk Despite Breast Plus Boost Radiotherapy Cite
    Truong P, Lupe K, Alexander C, Lesperance M, Tyldesley S. Subsets of Women with Close or Positive Margins after Breast Conserving Surgery with High Local Recurrence Risk Despite Breast Plus Boost Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2010; 78:S52-S53 10.1016/j.ijrobp.2010.07.157
  • Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Cite
    Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:170-178 10.1093/jnci/djp482
  • The importance of the lumpectomy surgical margin status in long term results of breast conservation Cite
    Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer. Wiley; 1995; 76:259-267 10.1002/1097-0142(19950715)76:2<259::aid-cncr2820760216>3.0.co;2-2
  • Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer Cite
    Kouzminova NB, Aggarwal S, Aggarwal A, Allo MD, Lin AY. Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer. The American Journal of Surgery. Elsevier BV; 2009; 198:771-780 10.1016/j.amjsurg.2009.05.027